294 related articles for article (PubMed ID: 32886190)
1. Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria.
Winther SA; Henriksen P; Vogt JK; Hansen TH; Ahonen L; Suvitaival T; Hein Zobel E; Frimodt-Møller M; Hansen TW; Hansen T; Parving HH; Legido-Quigley C; Rossing P; Pedersen O
Diabetologia; 2020 Dec; 63(12):2713-2724. PubMed ID: 32886190
[TBL] [Abstract][Full Text] [Related]
2. Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.
Pena MJ; Lambers Heerspink HJ; Hellemons ME; Friedrich T; Dallmann G; Lajer M; Bakker SJ; Gansevoort RT; Rossing P; de Zeeuw D; Roscioni SS
Diabet Med; 2014 Sep; 31(9):1138-47. PubMed ID: 24661264
[TBL] [Abstract][Full Text] [Related]
3. Multiomics signatures of type 1 diabetes with and without albuminuria.
Clos-Garcia M; Ahluwalia TS; Winther SA; Henriksen P; Ali M; Fan Y; Stankevic E; Lyu L; Vogt JK; Hansen T; Legido-Quigley C; Rossing P; Pedersen O
Front Endocrinol (Lausanne); 2022; 13():1015557. PubMed ID: 36531462
[TBL] [Abstract][Full Text] [Related]
4. Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin.
Huo L; Li H; Zhu M; Liu Y; Ren L; Hu J; Wang X
Front Endocrinol (Lausanne); 2023; 14():1257457. PubMed ID: 38075058
[TBL] [Abstract][Full Text] [Related]
5. Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition.
Koopen AM; de Clercq NC; Warmbrunn MV; Herrema H; Davids M; de Groot PF; Kootte RS; Bouter KEC; Nieuwdorp M; Groen AK; Prodan A
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32752028
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota mediate melatonin signalling in association with type 2 diabetes.
Huang X; Qiu Y; Gao Y; Zhou R; Hu Q; He Z; Lv Y; Wang X; Chen W; Deng Y; An Z; Zhang H; Mo Z; Lin R
Diabetologia; 2022 Oct; 65(10):1627-1641. PubMed ID: 35768541
[TBL] [Abstract][Full Text] [Related]
7. Aberrant intestinal microbiota in individuals with prediabetes.
Allin KH; Tremaroli V; Caesar R; Jensen BAH; Damgaard MTF; Bahl MI; Licht TR; Hansen TH; Nielsen T; Dantoft TM; Linneberg A; Jørgensen T; Vestergaard H; Kristiansen K; Franks PW; ; Hansen T; Bäckhed F; Pedersen O
Diabetologia; 2018 Apr; 61(4):810-820. PubMed ID: 29379988
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiome and metabolic activity in type 1 diabetes: An analysis based on the presence of GADA.
Luo S; Yue T; Liu Z; Yang D; Xu M; Ding Y; Jiang W; Xu W; Yan J; Weng J; Zheng X
Front Endocrinol (Lausanne); 2022; 13():938358. PubMed ID: 36246882
[TBL] [Abstract][Full Text] [Related]
9. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
Bryrup T; Thomsen CW; Kern T; Allin KH; Brandslund I; Jørgensen NR; Vestergaard H; Hansen T; Hansen TH; Pedersen O; Nielsen T
Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939
[TBL] [Abstract][Full Text] [Related]
10. Integrated 16S rRNA Gene Sequencing and LC-MS Analysis Revealed the Interplay Between Gut Microbiota and Plasma Metabolites in Rats With Ischemic Stroke.
Wu W; Sun Y; Luo N; Cheng C; Jiang C; Yu Q; Cheng S; Ge J
J Mol Neurosci; 2021 Oct; 71(10):2095-2106. PubMed ID: 33954858
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiome Composition and Serum Metabolome Profile Among Individuals With Spinal Cord Injury and Normal Glucose Tolerance or Prediabetes/Type 2 Diabetes.
Li J; Morrow C; Barnes S; Wilson L; Womack ED; McLain A; Yarar-Fisher C
Arch Phys Med Rehabil; 2022 Apr; 103(4):702-710. PubMed ID: 34126067
[TBL] [Abstract][Full Text] [Related]
12. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
Penno G; Russo E; Garofolo M; Daniele G; Lucchesi D; Giusti L; Sancho Bornez V; Bianchi C; Dardano A; Miccoli R; Del Prato S
Diabetologia; 2017 Jun; 60(6):1102-1113. PubMed ID: 28357502
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study.
Leiva-Gea I; Sánchez-Alcoholado L; Martín-Tejedor B; Castellano-Castillo D; Moreno-Indias I; Urda-Cardona A; Tinahones FJ; Fernández-García JC; Queipo-Ortuño MI
Diabetes Care; 2018 Nov; 41(11):2385-2395. PubMed ID: 30224347
[TBL] [Abstract][Full Text] [Related]
14. The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria.
Saleem T; Dahpy M; Ezzat G; Abdelrahman G; Abdel-Aziz E; Farghaly R
Appl Biochem Biotechnol; 2019 Jul; 188(3):854-867. PubMed ID: 30706418
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review.
Zhou H; Zhao X; Sun L; Liu Y; Lv Y; Gang X; Wang G
Dis Markers; 2020; 2020():3936247. PubMed ID: 32908614
[TBL] [Abstract][Full Text] [Related]
16. Connection Between BMI-Related Plasma Metabolite Profile and Gut Microbiota.
Ottosson F; Brunkwall L; Ericson U; Nilsson PM; Almgren P; Fernandez C; Melander O; Orho-Melander M
J Clin Endocrinol Metab; 2018 Apr; 103(4):1491-1501. PubMed ID: 29409054
[TBL] [Abstract][Full Text] [Related]
17. Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications Study.
Moriya T; Tanaka S; Kawasaki R; Ohashi Y; Akanuma Y; Yamada N; Sone H; Yamashita H; Katayama S;
Diabetes Care; 2013 Sep; 36(9):2803-9. PubMed ID: 23620478
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
[TBL] [Abstract][Full Text] [Related]
19. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
Cherney DZI; Zinman B; Inzucchi SE; Koitka-Weber A; Mattheus M; von Eynatten M; Wanner C
Lancet Diabetes Endocrinol; 2017 Aug; 5(8):610-621. PubMed ID: 28666775
[TBL] [Abstract][Full Text] [Related]
20. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
